Cargando…
Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial
AIMS: Atrial fibrillation (AF) is a common comorbidity in bradycardia patients. Advanced pacemakers feature atrial preventive pacing and atrial antitachycardia pacing (DDDRP) and managed ventricular pacing (MVP), which minimizes unnecessary right ventricular pacing. We evaluated whether DDDRP and MV...
Autores principales: | Boriani, Giuseppe, Tukkie, Raymond, Manolis, Antonis S., Mont, Lluis, Pürerfellner, Helmut, Santini, Massimo, Inama, Giuseppe, Serra, Paolo, de Sousa, João, Botto, Giovanni Luca, Mangoni, Lorenza, Grammatico, Andrea, Padeletti, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163193/ https://www.ncbi.nlm.nih.gov/pubmed/24771721 http://dx.doi.org/10.1093/eurheartj/ehu165 |
Ejemplares similares
-
Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmias
por: Crossley, George H., et al.
Publicado: (2019) -
Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
por: Sumiyoshi, Hironobu, et al.
Publicado: (2023) -
Atrial Antitachycardia Pacing in Complex Congenital Heart Disease: A Case Series
por: Kramer, Collin C., et al.
Publicado: (2018) -
Unsuccessful antitachycardia pacing: What is the mechanism?
por: Strik, Marc, et al.
Publicado: (2019) -
Dual chamber pacing mode in an atrial antitachycardia pacing device without a ventricular lead – A necessary evil
por: Noheria, Amit, et al.
Publicado: (2015)